Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma

This study is currently recruiting participants.
Verified April 2013 by Charite University, Berlin, Germany
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
PD Dr. Agnieszka Korfel, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00942747
First received: July 20, 2009
Last updated: April 15, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)